We are live on ! Find out more
IRD

Opus Genetics

33 hedge funds and large institutions have $6.23M invested in Opus Genetics in 2016 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

6% less funds holding

Funds holding: 3533 (-2)

14% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 7

38% less capital invested

Capital invested by funds: $10.1M → $6.23M (-$3.83M)

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

Holders
33
Holders Change
-2
Holders Change %
-5.71%
% of All Funds
0.88%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
6
Reduced
7
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
SM
1
Sabby Management
Florida
$1.99M +$99.1K +820 +4%
AFM
2
Anson Funds Management
Texas
$1.93M +$2.31M +19,104 New
Vanguard Group
3
Vanguard Group
Pennsylvania
$1.03M +$5.8K +48 +0.5%
Renaissance Technologies
4
Renaissance Technologies
New York
$672K +$213K +1,764 +36%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$192K
BIT
6
BlackRock Institutional Trust
California
$70K
Northern Trust
7
Northern Trust
Illinois
$45K
HVIA
8
Hudson Valley Investment Advisors
New York
$42K
TSS
9
Two Sigma Securities
New York
$39K +$46.6K +386 New
NFC
10
Northeast Financial Consultants
Connecticut
$31K
CCM
11
Condor Capital Management
New Jersey
$30K
Bank of New York Mellon
12
Bank of New York Mellon
New York
$26K -$4.83K -40 -13%
VKH
13
Virtu KCG Holdings
New York
$23K -$17.5K -145 -38%
BMC
14
Benin Management Corp
Connecticut
$20K +$2.54K +21 +12%
GC
15
Guggenheim Capital
Illinois
$14K -$121 -1 -0.7%
UBS Group
16
UBS Group
Switzerland
$13K -$11.8K -98 -44%
TRCT
17
Tower Research Capital (TRC)
New York
$10K +$8.7K +72 +267%
Goldman Sachs
18
Goldman Sachs
New York
$9K -$2.05K -17 -17%
BA
19
BlackRock Advisors
Delaware
$9K
State Street
20
State Street
Massachusetts
$9K
BFA
21
BlackRock Fund Advisors
California
$9K +$1.21K +10 +12%
Cambridge Investment Research Advisors
22
Cambridge Investment Research Advisors
Iowa
$7K
FHC
23
First Heartland Consultants
Missouri
$5K
ICOA
24
Investment Centers of America
North Dakota
$4K
NPT
25
Nixon Peabody Trust
Massachusetts
$2K

IRD Hedge Fund Activity: Q3 2016 in Review

33 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Opus Genetics (IRD) for Q3 2016, worth a combined $6.23M — down 38% from $10.1M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of IRD and 2 opened new positions — a net loss of 2 holders — while 7 trimmed existing stakes and 6 added.

The largest buyer was Anson Funds Management, opening a new position worth an estimated $2.31M. The largest seller was CSS LLC, exiting entirely with an estimated $5.21M sold.

  • 33 institutional investors held Opus Genetics (IRD) as of Q3 2016, down from 35 in Q2 2016.
  • Funds reported $6.23M of Opus Genetics stock for Q3 2016, down 38% quarter-over-quarter.
  • 2 funds opened new Opus Genetics positions in Q3 2016 and 4 closed out, a net change of -2 holders.
  • The largest Opus Genetics buyer in Q3 2016 was Anson Funds Management, an estimated $2.31M added.
  • The largest Opus Genetics seller in Q3 2016 was CSS LLC, an estimated $5.21M sold.

Based on aggregated 13F filings for Q3 2016.